Advanced search Help
Searching for terms: EXACT: "European Centre for Disease Prevention and Control" in: publisher
Clear all search criteria
Only 2/3! You are seeing results from the Public Collection, not the complete Full Collection. Sign in to search everything (see eligibility).
-
European Antimicrobial Resistance Surveillance Network (EARS-Net)
"EARS-Net is a European wide network of national surveillance systems, providing European reference data on antimicrobial resistance for public health purposes. The network is coordinated and funded by the European Centre for Disease Prevention and Control. The coordination of EARS-Net, the European Antimicrobial Resistance Surveillance Network (former EARSS), was transferred from the Dutch National Institute for Public Health and the Environment (RIVM) to the European Centre for Disease Prevention and Control (ECDC) in January 2010. [...] EARS-Net maintains a comprehensive surveillance and information system with European reference data on antimicrobial resistance for public health purposes. The results contribute to greater public awareness and scientific understanding of antimicrobial resistance and its importance in public health."
European Centre for Disease Prevention and Control
-
Best Practices in Ranking Emerging Infectious Disease Threats: A Literature Review
"The threat of serious, cross-border infectious disease outbreaks in Europe is a significant challenge in terms of emergency preparedness. Types of threats and the pathogens involved shift in response to changing factors such as climate change, global travel, immigration patterns, environmental degradation, and social inequalities. In order to effectively target the use of resources to manage the risks of outbreak, it is necessary to formulate rankings or prioritisation of human and/or animal pathogens."
European Centre for Disease Prevention and Control
2015-02
-
Disinfection of Environments in Healthcare and Non-Healthcare Settings Potentially Contaminated with SARS-COV-2
From the Background: "SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] virus has been detected in respiratory secretions (upper and lower respiratory tract) and faeces. The main route of transmission is considered to be through inhalation of large respiratory droplets or deposition on mucosae. Viral RNA [ribonucleic acid], has been detected in blood but there is no evidence that SARS-CoV-2 can be transmitted through contact with blood. Contact with contaminated fomites due to persistence of the virus on surfaces is another route implicated in the transmission of SARS-CoV-2 virus. Faecal-oral and airborne modes have also been considered, but their role in the transmission of SARS-CoV-2 is currently unknown. In order to reduce the risk of infection through fomites, it is essential to establish procedures for the correct disinfection of environments that could have been contaminated with SARS-CoV-2."
European Centre for Disease Prevention and Control
Baka, Agoritsa; Cenciarelli, Orlando; Ciancio, Bruno . . .
2020-03
-
Updated Rapid Risk Assessment: Severe Respiratory Disease Associated with Middle East Respiratory Syndrome Coronavirus (MERS-CoV), Eleventh Update
"Since the last ECDC [European Centre for Disease Prevention and Control] rapid risk assessment, published on 31 May 2014, the number of incident cases has been steadily declining and from 10 July to 20 August 2014, only two cases of MERS-CoV [Middle East Respiratory Syndrome Coronavirus] were reported. The cases currently occurring seem to be sporadic. While the virus continues to circulate in the affected region at a lower frequency, uncertainties in the reservoir of the virus and possible community transmission remain. Following detection of imported cases in Europe, transmission chains have been very limited and appropriate infection control and contact tracing methods appear to be effective in limiting further transmission in a European setting. Extensive contact tracing efforts for flights on which probable or confirmed cases have travelled have so far not shown evidence of transmission to other passengers. Therefore the current risk of human infections and sustainable human-to-human transmission in Europe remains low."
European Centre for Disease Prevention and Control
2014-08-21
-
Influenza Pandemic Preparedness in Ireland: Joint Assessment Report, 2007
This report was created "to support national Irish authorities in jointly evaluating and improving the status of pandemic influenza preparedness in Ireland, including the interoperability of its plans with other countries in Europe" and to evaluate the current status of preparedness for influenza. The report has a special focus on "strengths of pandemic influenza preparedness and areas where further work is needed and specific steps for improvement and areas where support from the European Centre for Disease Prevention and Control (ECDC) and other organizations may be requested. The end product is an agreed recommended action list for improvement and a follow-up programme which also clarifies the further support needed from the ECDC."
European Centre for Disease Prevention and Control
2007
-
Coronavirus Disease - 2019 (COVID-19) and Supply of Substances of Human Origin in EU/EEA - First Update
From the Scope of the Document: "This first update of the original document is prompted by the recent scientific developments and evolution of the coronavirus 2019 (COVID-19) pandemic and the need to include types of substances of human origin (SoHO) that were not addressed in the first version (e.g. reproductive and some non-reproductive tissues and cells). The document aims to provide a risk assessment and management options for the safe and sustainable supply of SoHO to assist the European Union and European Economic Area (EU/EEA) Member States in responding to the threat posed by the COVID-19 pandemic. Following the rapid spread of COVID-19 in the EU/EEA and worldwide, the European Centre for Disease Prevention and Control (ECDC) has been publishing rapid risk assessments and setting out measures on how to maintain the safety and sustainability of SoHO supply. These documents have also advocated the activation of pandemic plans to prepare for large outbreaks and community transmission of COVID-19. The first version of this document and the current update also consider the current evidence available on other viral respiratory pathogens, mainly the Severe Acute Respiratory Syndrome coronavirus (SARSCoV), the Middle East Respiratory Syndrome-related coronavirus (MERS-CoV), and seasonal or pandemic influenza viruses. ECDC will update the document as and when new relevant information becomes available, or as required by the epidemiological situation."
European Centre for Disease Prevention and Control
2020-04
-
Considerations for Infection Prevention and Control Measures on Public Transport in the Context of COVID-19
From the Scope of the Document: "This document provides advice on personal protective measures on public transport (e.g. bus, metro, train, commuter boats)."
European Centre for Disease Prevention and Control
Baka, Agoritsa; Brusin, Sergio; Cenciarelli, Orlando . . .
2020-04-29
-
Immunisation: What is Community Immunity and Why is it Important?
From the Document: "Vaccination protects you and your family, and it also helps protect others. It contributes to 'community immunity'. This is achieved when enough people in a population are immune to an infectious disease (through vaccination and/or prior illness) so that it is unlikely to spread from person to person. Even those who cannot be vaccinated because they are too young, are allergic to vaccine components, or vaccination is contraindicated for them, are offered some protection because the disease cannot spread in the community and infect them. This is also known as 'herd immunity'."
European Centre for Disease Prevention and Control
-
Coronavirus Disease 2019 (COVID-19) in the EU/EEA and the UK -- Ninth Update
From the Summary: "Since 31 December 2019 and as of 22 April 2020, approximately 2.5 million (2 524 812) cases of COVID-19 [coronavirus disease 2019] have been reported worldwide and 177 780 deaths. Of these, 988 241 cases were reported by EU/EEA [European Union/European Economic Area] countries and the UK, including 105 064 deaths. The COVID-19 pandemic is posing an unprecedented threat to EU/EEA countries and the UK, which have been experiencing widespread transmission of the virus in the community for several weeks. In addition, there has been an increasing number of reports of COVID-19 outbreaks in long-term care homes across Europe with high associated mortality, highlighting the extreme vulnerability of the elderly in this setting. The absence of an effective treatment or a vaccine combined with an exponential growth in infections from late February, led many countries to implement non-pharmaceutical interventions such as 'stay-at-home' policies (recommended or enforced) alongside other community and physical distancing measures such as the cancellation of mass gatherings, closure of educational institutions and public spaces. This approach has collectively reduced transmission and the 14-day incidence in the EU/EEA and the UK overall has declined by 18% since 8 April. In 20 EU/EEA countries, it appears that the initial wave of transmission has passed its peak, with a decline in the number of newly reported cases."
European Centre for Disease Prevention and Control
2020-04-23
-
Contact Tracing for COVID-19: Current Evidence, Options for Scale-Up and an Assessment of Resources Needed
From the Summary: "Contact tracing is an effective public health measure for the control of COVID-19 [coronavirus disease 2019]. The prompt identification and management of the contacts of COVID-19 cases makes it possible to rapidly identify secondary cases that may arise after transmission from the primary cases. This will enable the interruption of further onward transmission. Contact tracing, in conjunction with robust testing and surveillance systems, is central to control strategies during de-escalation. Contact tracing has been a key part of the response in several Asian countries that have successfully reduced case numbers. It is possible to scale up contact tracing by adapting traditional contact tracing approaches to available local resources and by using a number of resource-saving measures. This document outlines a number of resource measures including the use of well-trained non-public-health staff and volunteers; repurposing existing resources such as call centres; reducing the intensity of contact follow-up and using new technologies such as contact management software and mobile apps."
European Centre for Disease Prevention and Control
2020-04
-
Guidance for Discharge and Ending Isolation in the Context of Widespread Community Transmission of COVID-19 - First Update
From the Scope: "This document provides guidance for planning discharge and ending isolation for COVID-19 [coronavirus disease] patients in the context of the phase of ongoing widespread community transmission."
European Centre for Disease Prevention and Control
2020-04-08
-
Interim Guidance for Environmental Cleaning in Non-Healthcare Facilities Exposed to SARS-CoV-2
From the Scope: "This document aims to provide guidance about the environmental cleaning in non-healthcare facilities (e.g. rooms, public offices, transports, schools, etc.) where confirmed COVID-19 [coronavirus disease] cases have been before being admitted to hospital. This guidance is based on the current knowledge about SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] and evidence originating from studies on other coronaviruses."
European Centre for Disease Prevention and Control
2020-02-18
-
Coronavirus Disease 2019 (COVID-19) in the EU/EEA and the UK - Eighth Update
From the Summary: "Since 31 December 2019 and as of 7 April 2020, over 1.3 million (1 316 988) cases of COVID-19 have been reported worldwide, and more than 70 000 (74 066) deaths. Half of these cases (608 500) have been reported from the EU/EEA [European Union/European Economic Area] countries and the UK, and over 50 000 (51 059) of them have died. Overall, large increases in COVID-19 cases and deaths continue to be reported from the EU/EEA countries and the UK. In addition, in recent weeks, the European all-cause mortality monitoring system showed all-cause excess mortality above the expected rate in Belgium, France, Italy, Malta, Spain, Switzerland and the United Kingdom, mainly in the age group of 65 years and above. Recently, in a few EU/EEA countries, the number of new cases and new deaths reported daily appears to have decreased slightly. However, many EU/EEA countries are currently only testing severe or hospitalised cases, therefore these trends should be interpreted with caution. Despite early evidence from Italy and Austria that the number of cases and deaths are declining, there is currently no indication at EU/EEA level that the peak of the epidemic has been reached."
European Centre for Disease Prevention and Control
2020-04-08
-
Guidance for Wearing and Removing Personal Protective Equipment in Healthcare Settings for the Care of Patients with Suspected or Confirmed COVID-19
From the Scope: "This document provides support to healthcare workers managing suspected or confirmed cases of novel coronavirus 2019 (COVID-19). The general objectives of the document are: [1] to present the minimal set of personal protective equipment (PPE) required for managing suspected or confirmed COVID-19 cases; [2] to make healthcare workers aware of the critical aspects of the donning and doffing of PPE; and [3] to strengthen occupational safety in healthcare workers for patients suspected of, or confirmed with, COVID19. This document is based on current COVID-19 knowledge and PPE best practices. ECDC will update this document based on the evolving situation and if new relevant information arises."
European Centre for Disease Prevention and Control
2020-02
-
Leaflet: Information on Self-Isolation and Quarantine After Exposure to COVID-19
From the Webpage Description: "This leaflet provides basic information on novel coronavirus disease (COVID-19), how it spreads, symptoms, how to avoid catching or spreading the virus, and some specific advice and rules on self-isolation or quarantine when presenting mild symptoms of COVID-19 or after exposure to the SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] virus."
European Centre for Disease Prevention and Control
2020-03-12?
-
Using Face Masks in the Community: Reducing COVID-19 Transmission from Potentially Asymptomatic or Pre-Symptomatic People Through the Use of Face Masks
From the Scope: "This document provides the ECDC [European Centre for Disease Prevention and Control] opinion on the suitability of face masks and other face covers in the community by individuals who are not ill in order to reduce potential pre-symptomatic or asymptomatic transmission of COVID-19 [coronavirus disease] from the mask wearer to others."
European Centre for Disease Prevention and Control
2020-04-08
-
Contact Tracing: Public Health Management of Persons, Including Healthcare Workers, Having Had Contact with COVID-19 Cases in the European Union - Second Update
From the Background: "This document outlines the key steps of contact tracing, including contact identification, listing and follow-up, in the context of the COVID-19 [coronavirus disease] response."
European Centre for Disease Prevention and Control
2020-04-08
-
Strategies for the Surveillance of COVID-19
From the Background: "All EU/EEA [European Union/European Economic Area] Member States and the United Kingdom are seeing widespread community transmission of coronavirus disease (COVID-19) and have implemented extensive public health, societal and economic measures to flatten the epidemic curve and avert overload or collapse of their healthcare systems. This document proposes an updated strategy for COVID-19 surveillance at national and EU/EEA level that specifically aims to reconcile the data needs for effective pandemic response with what is still feasible in countries and within healthcare systems under siege, while taking into account guidance issued by the World Health Organization."
European Centre for Disease Prevention and Control
2020-04-09
-
Contact Tracing: Public Health Management of Persons, Including Healthcare Workers, Having Had Contact with COVID-19 Cases in the European Union - First Update
From the Scope: "This document aims to help EU/EEA [European Union/ European Economic Area] public health authorities in the tracing and management of persons, including healthcare workers, who had contact with COVID-19 [coronavirus disease] cases."
European Centre for Disease Prevention and Control
2020-03-31
-
Infection Prevention and Control and Preparedness for COVID-19 in Healthcare Settings: Second Update - 31 March 2020
From the Scope: "This document aims to provide guidance to EU/EEA [European Union/European Economic Area] healthcare facilities and healthcare providers on infection prevention and control (IPC) measures for the management of suspected and confirmed cases of COVID-19 [coronavirus disease] infection in healthcare settings, including long-term care facilities. It also offers guidance on the management of specimens at laboratories in the EU/EEA. This is an update of the ECDC [European Centre for Disease Prevention and Control] guidance dated 12 March 2020 'Infection prevention and control for COVID-19 in healthcare settings'. This update focuses on measures to be applied in settings with increasing community transmission, a growing demand for care of COVID-19 patients and ensuing staff issues in the event of shortages of personal protective equipment (PPE) for healthcare facilities in EU/EEA countries and the United Kingdom."
European Centre for Disease Prevention and Control
2020-03-31
-
Novel Coronavirus (SARS-CoV-2): Discharge Criteria for Confirmed COVID-19 Cases - When is it Safe to Discharge COVID-19 Cases from the Hospital or End Home Isolation?
From the Document: "This document has been produced upon request of an EU/EEA [European Union/European Economic Area]Member State. It suggests criteria to be considered when deciding whether a confirmed COVID-19 case can be safely (i.e. without being infectious) discharged from hospital or released from home isolation. To address this request, the following working questions were developed: [1] What is the duration of SARS-CoV-2 virus [severe acute respiratory syndrome-related coronavirus] shedding in bodily fluids of symptomatic patients after remission of symptoms? [2] What is the duration of SARS-CoV-2 virus shedding in bodily fluids of asymptomatic patients? [3] Which tests are available to document the lack of infectivity in a previously diagnosed infection? [4] What is the longest documented transmission from an asymptomatic person?"
European Centre for Disease Prevention and Control
2020-03-10?
-
Cloth Masks and Mask Sterilisation as Options in Case of Shortage of Surgical Masks and Respirators
From the Scope: "This document aims to provide advice on the use of cloth face masks and sterilisation of respirators and surgical masks as an alternative in healthcare settings with suspected or confirmed COVID-19 [coronavirus disease 2019] cases if there is a shortage of specialised surgical masks and respirators."
European Centre for Disease Prevention and Control
2020-03-26
-
Infection Prevention and Control in the Household Management of People with Suspected or Confirmed Coronavirus Disease (COVID-19)
From the Scope: "This document provides guidance on infection prevention and control (IPC) measures for people with suspected or confirmed coronavirus disease (COVID-19) who are experiencing mild symptoms that do not require hospitalisation, therefore self-isolating at home."
European Centre for Disease Prevention and Control
2020-03-30
-
Download Today's Data on the Geographic Distribution of COVID-19 Cases Worldwide
From the Webpage: "The downloadable data file is updated daily and contains the latest available public data on COVID-19 [coronavirus disease]. Public-use data files allows users to manipulate the data in a format appropriate for their analyses. Users of ECDC [European Centre for Disease Prevention and Control] public-use data files must comply with data use restrictions to ensure that the information will be used solely for statistical analysis or reporting purposes."
European Centre for Disease Prevention and Control
-
Considerations Relating to Social Distancing Measures in Response to COVID-19 - Second Update
From the Scope: "This document aims to support public health preparedness planning and response activities based upon social distancing measures aimed at minimising the spread of COVID-19 [coronavirus disease]. Social distancing is an action taken to minimise contact with other individuals; social distancing measures comprise one category of non-pharmaceutical countermeasures (NPCs) aimed at reducing disease transmission and thereby also reducing pressure on health services."
European Centre for Disease Prevention and Control
2020-03-23
-
Considerations Related to the Safe Handling of Bodies of Deceased Persons with Suspected or Confirmed COVID-19
From the Scope: "This document aims to support public health preparedness planning and response activities on the safe handling of bodies of deceased persons with suspected or confirmed COVID-19 [Coronavirus Disease]: at the site of death, during transport, storage and preparation before burial/cremation, and during burial/cremation."
European Centre for Disease Prevention and Control
2020
-
Guidance for Health System Contingency Planning During Widespread Transmission of SARS-CoV-2 with High Impact on Healthcare Services
From the Document: "This document aims to support public health preparedness planning and response activities when advising healthcare services on approaches on how to increase capacity for managing COVID-19 cases in the context of widespread sustained SARS [severe acute respiratory syndrome]-CoV-2 transmission in a particular community. The guidance is based on expert opinion, on the publication 'Potential scenarios for the progression of a COVID-19 epidemic in the European Union and the European Economic Area, March 2020', on the ECDC [European Centre for Disease Prevention and Control] 'Rapid risk assessment: Outbreak of novel coronavirus disease 2019 (COVID-19): increased transmission globally - sixth update', the ECDC 'Checklist for hospitals preparing for the reception and care of coronavirus 2019 (COVID-19) patients' and the ECDC 'Health emergency preparedness for imported cases of high-consequence infectious diseases'."
European Centre for Disease Prevention and Control
2020-03
-
Coronavirus Disease 2019 (COVID-19) and Supply of Substances of Human Origin in the EU/EEA
From the Scope of the Document: "This document aims to provide a risk assessment and management options for the safe and sustainable supply of substances of human origin (SoHO) to assist the European Union and European Economic Area (EU/EEA) Member States in responding to the threat posed by the coronavirus disease 2019 (COVID-19) pandemic. Following the rapid spread of COVID-19 in the EU/EEA and worldwide, the European Centre for Disease Prevention and Control (ECDC) has published a set of rapid risk assessments and set out measures on how to maintain the safety and sustainability of SoHO supply. It has also been advocating for EU/EEA Member States to activate pandemic plans to prepare for large outbreaks and community transmission of COVID-19. This document is based on current knowledge concerning COVID-19 and evidence available on other viral respiratory pathogens, mainly the Severe Acute Respiratory Syndrome coronavirus (SARS-CoV), the Middle East Respiratory Syndrome-related coronavirus (MERS-CoV), and seasonal or pandemic influenza viruses. ECDC will update the document as and when new relevant information becomes available, or as required by the epidemiological situation."
European Centre for Disease Prevention and Control
2020-03-20
-
Methodology for Estimating Point Prevalence of SARS-CoV-2 Infection by Pooled RT-PCR Testing
From the Scope: "The scope of this document is to provide EU/EEA [European Union/European Economic Area] Member States and the UK with technical guidance for estimating the prevalence of SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] infected cases, through a cross sectional study design based on pooled sampling for RT-PCR [Reverse Transcription-Polymerase Chain Reaction] testing on a random population sample. The proposed methodology is for surveillance purposes and does not address pooled testing for clinical (i.e. diagnostic) or public health (e.g. contact tracing, infection prevention and control, screening) management of individuals. The goal is to provide a tool to monitor the activity of the disease with high efficiency in terms of laboratory resources. The methodology provides a way to estimate prevalence from the results of a pooled RT-PCR test, without the need to identify individual test results, and the statistical foundation for the strategy."
European Centre for Disease Prevention and Control
2020-05-28
-
Updated Rapid Risk Assessment: Severe Respiratory Disease Associated with Middle East Respiratory Syndrome Coronavirus (MERS-CoV), Ninth Update, 24 April 2014
From the "Public health issue" section of the report: "This ninth update of the rapid risk assessment of the MERS-CoV [Middle East Respiratory Syndrome Coronavirus] outbreak addresses the following public health question: Has the risk to EU citizens from the transmission of MERS-CoV in the Middle East changed since the last update of the risk assessment of 6 November 2013, considering: [1] the updated epidemiological information [2] the recent findings of increased number of infections in healthcare workers (HCW) and suspicion of nosocomial transmission, and asymptomatic infections in close contacts [3] the updated scientific evidence on the virus and the animal reservoir (camels)."
European Centre for Disease Prevention and Control
2014-04-24
